TW200621309A - Propiverine-containing oral particulate preparation and process for producing the same - Google Patents

Propiverine-containing oral particulate preparation and process for producing the same

Info

Publication number
TW200621309A
TW200621309A TW094137826A TW94137826A TW200621309A TW 200621309 A TW200621309 A TW 200621309A TW 094137826 A TW094137826 A TW 094137826A TW 94137826 A TW94137826 A TW 94137826A TW 200621309 A TW200621309 A TW 200621309A
Authority
TW
Taiwan
Prior art keywords
propiverine
preparation
producing
same
particulate preparation
Prior art date
Application number
TW094137826A
Other languages
Chinese (zh)
Inventor
Tetsuo Ogata
Atsuo Koide
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of TW200621309A publication Critical patent/TW200621309A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

An oral preparation with good sensation takes contains generally procurable propiverine hydrochloride as a medicinal ingredient so as to be made, and can avoid any lowering of patients' dosing compliance. The particulate preparation can be produced by obtaining a suspension resulting from mixing of propiverine hydrochloride, a surfactant, a pH adjusting agent and water and having its pH value adjusted so as to fall within the range of 6.5 to 8.0 with the pH adjusting agent, and subsequently granulating the suspension together with common additives for preparation.
TW094137826A 2004-10-29 2005-10-28 Propiverine-containing oral particulate preparation and process for producing the same TW200621309A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004315212 2004-10-29

Publications (1)

Publication Number Publication Date
TW200621309A true TW200621309A (en) 2006-07-01

Family

ID=36227801

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094137826A TW200621309A (en) 2004-10-29 2005-10-28 Propiverine-containing oral particulate preparation and process for producing the same

Country Status (3)

Country Link
JP (1) JP4895819B2 (en)
TW (1) TW200621309A (en)
WO (1) WO2006046560A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI519322B (en) * 2008-04-15 2016-02-01 愛戴爾製藥股份有限公司 Compositions comprising weakly basic drugs and controlled-release dosage forms
JP2013231011A (en) * 2012-05-01 2013-11-14 Sawai Pharmaceutical Co Ltd Atorvastatin-containing pharmaceutical composition and orally disintegrating tablet using the same
EP3331502B1 (en) 2015-08-07 2021-05-26 Santa Farma Ilaç Sanayi A.S. Controlled release propiverine formulations
WO2020101586A1 (en) 2018-11-16 2020-05-22 Santa Farma İlaç Sanayi̇ A.Ş. Controlled release propiverine formulations
EP4251154A1 (en) 2020-11-27 2023-10-04 Santa Farma Ilac Sanayii A.S. Sustained release formulation compositions comprising propiverine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4346817B2 (en) * 1997-09-30 2009-10-21 第一三共ヘルスケア株式会社 Oral preparation
JP2002249432A (en) * 2000-12-22 2002-09-06 Takeda Chem Ind Ltd Combined agent
PL200270B1 (en) * 2001-02-27 2008-12-31 Roehm Gmbh Coating and binding agent for pharmaceutical formulations with improved storage stability
DE10109763A1 (en) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmaceutical salts
DE10149674A1 (en) * 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orally administered composition for sustained release of propiverine, useful for treatment of hypertonic bladder disorders, especially by once-daily administration
KR20050005410A (en) * 2002-02-19 2005-01-13 파마시아 코포레이션 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
DE10239999A1 (en) * 2002-08-27 2004-03-04 Röhm GmbH & Co. KG Granules or powders for the preparation of coating and binding agents for dosage forms

Also Published As

Publication number Publication date
JP4895819B2 (en) 2012-03-14
WO2006046560A1 (en) 2006-05-04
JPWO2006046560A1 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
RS52233B (en) Farmaceutical dosage form comprising pellets as well as its manufacturing process
MXPA06000716A (en) Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors.
TW200607799A (en) Therapeutic compounds: pyridine as scaffold
UA91401C2 (en) 4-[(3-chloro-4-fluorophenyl)amino]-6-{[4-(n,n-dimethylamino)-1-oxo-2-butene-1-yl]amino}-7-((s)-tetrahydrofurane-3-yloxy)-quinazoline maleate, production method and uses thereof
TW200716628A (en) Novel compounds
DE602005025977D1 (en) CRYSTALLINE FORM OF IBANDRONATE SODIUM AND METHOD OF MANUFACTURING THEREOF
TW200626598A (en) Pyrrazolo-pyrimidine derivatives
GEP20084417B (en) Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
HK1088217A1 (en) Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
WO2004108715A8 (en) 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity
TW200716204A (en) Pharmaceutical composition
TW200633964A (en) Tetralin and indane derivatives and uses thereof
TW200621309A (en) Propiverine-containing oral particulate preparation and process for producing the same
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
TW200612930A (en) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
SE0301701D0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200504030A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SI1589014T1 (en) Process for the preparation of 1,3-dihydro-2H-3-benzazepin-2-one and application to the preparation of ivabradine and their pharmaceutically acceptable salts
MXPA05007484A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof.
GEP20074075B (en) Indazolamides with analgesic activity
WO2005094798A3 (en) Pharmaceutical compositions based on anticholinergics and ccr2 receptor antagonists
WO2002069944A3 (en) Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists
GEP20074183B (en) Indazole having analgesic activity